Cerebrolysin Peptide

Cerebrolysin Peptide is a porcine-brain-derived peptide complex containing biologically active neuropeptides and free amino acids. This research-grade lyophilized concentrate is produced under strict GMP conditions and provided with full analytical documentation. For Research Use Only. Not for human use.

Key Scientific Attributes

• High-purity Cerebrolysin peptide fraction (15% peptides <10 kDa, 85% free amino acids)
• Lyophilized concentrate (215.2 mg solids per vial)
• Full Certificate of Analysis (COA) with HPLC, amino acid profile, molecular weight distribution, and in-vitro neuroprotection assay
• Manufactured in GMP-aligned, ISO-compliant facilities
• Suitable for neurological and neuroregeneration research applications

Research-Referenced Attributes (Based on preclinical literature; not therapeutic claims.)

• Research into neurotrophic factor modulation, including BDNF and NGF pathways, in ischemic brain tissue models
• Investigated for effects on amyloid-β and tau phosphorylation in preclinical research models
• Studied in preclinical models of brain and spinal cord injury
• Subject of ongoing scientific investigation into neuroprotective mechanisms (onlinelibrary.wiley.com)

Why Researchers Choose Cerebrolysin Peptide

• Pharmaceutical-grade composition suitable for use in clinical and preclinical research studies
• Transparent analytical data (peptide MW profile + in-vitro neuroprotection assay)
• Competitive research pricing with bulk options

For Research Use Only. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any condition.